The records of all patients undergoing breast surgery at one institution over a 6-year period were retrospectively reviewed. Twenty-two cases were found to meet the criteria for designation as medullary carcinoma of the breast. Estrogen receptor assay was performed in 20 cases and was negative in 75
Is medullary carcinoma of the breast hormone dependent?
โ Scribed by J. K. Patel; T. Nemoto; T. L. Dao
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 170 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
From 1951 to 1981, 22 patients with metastatic medullary carcinoma of the breast were treated with hormonal therapies at Roswell Park Memorial Institute. Bilateral oophorectomy was performed in 6 premenopausal patients, and none had objective response, although one patient did have stable disease for 7 months. Three of these patients subsequently underwent bilateral adrenalectomy and none responded. Thirteen of 16 postmenopausal patients underwent bilateral adrenalectomy and only one had an objective response of 4 monlhs. Eight of 22 patients received additive hormones, and one patient was treated with Tamoxifen. There was no ob.jective response to these therapies. From this study, it appears that medullary carcinoma of the breast is less often responsive to endocrine therapy, and this finding correlates well with the recent data showing lower frequency of estrogen rcceptor-positive tumors in these patients.
๐ SIMILAR VOLUMES
Quantitative determination of the estrogen receptor (estrophilin) content of a n excised tumor specimen provides information useful in selecting the type of systemic therapy best suited to the individual patient with advanced breast cancer. Women whose tumors contain low or negligible amounts of est
## Abstract ## BACKGROUND To investigate the role of primary hypothyroidism (HYPT) on breast carcinogenesis, the authors evaluated 1) the association between HYPT and a diagnosis of invasive breast carcinoma and 2) the clinicopathologic characteristics of breast carcinoma in patients with HYPT. #